v3 Template
I

Igyxos Biotherapeutics

Biotechnology / Healthcare ~560 employees
Founded
--
Employees (Est.)
~560
28 leaders known
Total Funding
$6.3M
Funding Rounds
1
Last Funding
2025-10-02

About Igyxos Biotherapeutics

Igyxos Biotherapeutics is dedicated to transforming infertility treatment through breakthrough science in monoclonal antibodies. The company focuses on improving reproductive health outcomes for men and women by pioneering novel therapeutics that enhance the effectiveness, efficiency, and economics of infertility treatments.

Products & Services

IGX12:Igyxos' first clinical candidate with compelling preclinical data, aimed at increasing the efficacy and potency of Follicle Stimulating Hormone (FSH) in reproduction.

Specialties

Infertility Treatment Monoclonal Antibodies Reproductive Health Follicle Stimulating Hormone (FSH) Enhancement

Funding History

Debug: View Raw Funding Data
# Type Amount Fields Date Fields Investors
1 RT: Grant
T: -
FT: Grant 		A: 6270000
MR: -
FA: EUR 5.7 million
FAN: 6270000 		D: 2025-10-02
FD: 2025-10-02 		2 investors
Grant Latest
2025-10-02
$6.3M
2 investors (Pro only)

Growth Metrics

+45%
Employee Growth
YoY
3.2x
Funding Growth
Last Round
12
Markets
Operating
10K+
Customers
Active

View 3 more growth metrics with Pro

Unlock All Metrics
Mock Up

Team & Leadership

R

René Frydman

Professor

P

Philippe Bouchard

Professor

D

Didier Dewailly

Professor

P

Peter Schlegel

Professor of Urology & Reproductive Medicine

N

Nelly Pitteloud

Professor

J

Juan Garcia-Velasco

Director of the IVI clinic

View 25 more team members with Pro

Unlock Full Team Directory

Recent News

Igyxos Biotherapeutics Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Read more →

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Read more →

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Read more →

View 2 more news articles with Pro

Unlock Full News Feed
Mock Up

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised

Mock Up

Company Details

Website
igyxos.com
Industries
Biotechnology / Healthcare
Company Size
~560 employees (est.)

Similar Companies

Discover AI-powered company recommendations based on industry, funding, and team profiles.

Upgrade to Pro

Technology Stack

Discover the backend, frontend, and infrastructure technologies powering this company's products.

Upgrade to Pro